loading
前日終値:
$1.10
開ける:
$1.1
24時間の取引高:
87,139
Relative Volume:
0.29
時価総額:
$59.28M
収益:
$96.63M
当期純損益:
$-63.32M
株価収益率:
-0.7979
EPS:
-1.46
ネットキャッシュフロー:
$-54.55M
1週間 パフォーマンス:
-0.84%
1か月 パフォーマンス:
-30.59%
6か月 パフォーマンス:
-58.89%
1年 パフォーマンス:
-69.74%
1日の値動き範囲:
Value
$1.10
$1.20
1週間の範囲:
Value
$1.02
$1.2399
52週間の値動き範囲:
Value
$1.01
$4.65

Akoya Biosciences Inc Stock (AKYA) Company Profile

Name
名前
Akoya Biosciences Inc
Name
セクター
Healthcare (1155)
Name
電話
855.896.8401
Name
住所
100 CAMPUS DRIVE, MARLBOROUGH
Name
職員
205
Name
Twitter
Name
次回の収益日
2025-03-17
Name
最新のSEC提出書
Name
AKYA's Discussions on Twitter

AKYA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Instruments & Supplies icon
AKYA
Akoya Biosciences Inc
1.165 59.28M 96.63M -63.32M -54.55M -1.46
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
476.05 175.60B 8.35B 2.32B 1.30B 6.41
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
198.85 57.39B 20.64B 1.73B 2.94B 6.02
Medical Instruments & Supplies icon
ALC
Alcon Inc
93.25 45.22B 9.91B 1.02B 665.00M 2.05
Medical Instruments & Supplies icon
RMD
Resmed Inc
213.53 31.43B 4.93B 1.25B 1.38B 8.47
Medical Instruments & Supplies icon
COO
The Cooper Companies, Inc.
79.38 15.88B 3.90B 392.30M 288.10M 1.95

Akoya Biosciences Inc Stock (AKYA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-11-15 ダウングレード Craig Hallum Buy → Hold
2024-08-06 ダウングレード BTIG Research Buy → Neutral
2024-08-06 ダウングレード JP Morgan Overweight → Neutral
2024-08-06 ダウングレード Morgan Stanley Overweight → Equal-Weight
2024-06-21 開始されました Craig Hallum Buy
2023-12-14 開始されました Guggenheim Neutral
2023-07-05 再開されました JP Morgan Overweight
2023-02-02 開始されました UBS Buy
2022-11-03 開始されました CapitalOne Overweight
2022-10-06 開始されました Stephens Overweight
2022-06-22 開始されました BTIG Research Buy
2022-01-06 再開されました Piper Sandler Overweight
2021-05-11 開始されました Canaccord Genuity Buy
2021-05-11 開始されました JP Morgan Overweight
2021-05-11 開始されました Morgan Stanley Overweight
2021-05-11 開始されました Piper Sandler Overweight
すべてを表示

Akoya Biosciences Inc (AKYA) 最新ニュース

pulisher
Apr 17, 2025

Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders - Business Wire

Apr 17, 2025
pulisher
Apr 15, 2025

Akoya Biosciences (NASDAQ:AKYA) Given New $1.65 Price Target at Piper Sandler - Defense World

Apr 15, 2025
pulisher
Apr 14, 2025

Tikvah Management Calls on Quanterix to Explain the Egregious Te - GuruFocus

Apr 14, 2025
pulisher
Apr 14, 2025

Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences - Bluefield Daily Telegraph

Apr 14, 2025
pulisher
Apr 14, 2025

Quanterix Faces Investor Backlash: $30M Convertible Notes Deal Under Fire - Stock Titan

Apr 14, 2025
pulisher
Apr 09, 2025

Akoya Biosciences, Inc. (NASDAQ:AKYA) Given Consensus Recommendation of “Hold” by Analysts - Defense World

Apr 09, 2025
pulisher
Apr 07, 2025

Akoya Biosciences stock hits 52-week low at $1.07 amid market challenges By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

Akoya Biosciences stock hits 52-week low at $1.07 amid market challenges - Investing.com India

Apr 07, 2025
pulisher
Apr 07, 2025

Quanterix Under Fire: Top Investor Warns of 'Value Destructive' $30M Deal with Struggling Akoya - Stock Titan

Apr 07, 2025
pulisher
Apr 04, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – OPTN, SLRN, AKYA, SHYF - GlobeNewswire Inc.

Apr 04, 2025
pulisher
Apr 04, 2025

Akoya BiosciencesOn April 2, Entered Securities Purchase Agreement With Quanterix Corporation - MarketScreener

Apr 04, 2025
pulisher
Apr 04, 2025

Spatial Genomics and Transcriptomics Industry Analysis Report 2025, Featuring Detailed Profiles of Leading Players10x Genomics, Bruker Corp., Akoya Biosciences, and Bio-Techne Among OthersResearchAndMarkets.com - Bluefield Daily Telegraph

Apr 04, 2025
pulisher
Apr 02, 2025

Akoya Biosciences and Team SAMBAI Announce Selection of the - GlobeNewswire

Apr 02, 2025
pulisher
Apr 02, 2025

Akoya Biosciences And Team SAMBAI Select PhenoCycler-Fusion For Cancer Equity Research - Nasdaq

Apr 02, 2025
pulisher
Apr 02, 2025

Akoya Biosciences and Team SAMBAI Announce Selection of the PhenoCycler®-Fusion as the Foundational Spatial Proteomics Technology for Large-Scale Study to Address Cancer Inequities - Yahoo Finance

Apr 02, 2025
pulisher
Mar 31, 2025

Short Interest in Akoya Biosciences, Inc. (NASDAQ:AKYA) Decreases By 30.8% - The AM Reporter

Mar 31, 2025
pulisher
Mar 30, 2025

Akoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Down 30.8% in March - Defense World

Mar 30, 2025
pulisher
Mar 28, 2025

Akoya Biosciences stock hits 52-week low at $1.39 amid market challenges By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

Akoya Biosciences stock hits 52-week low at $1.39 amid market challenges - Investing.com India

Mar 28, 2025
pulisher
Mar 26, 2025

This Waters Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday - Benzinga

Mar 26, 2025
pulisher
Mar 26, 2025

Akoya Biosciences’ (AKYA) Equal Weight Rating Reaffirmed at Stephens - Defense World

Mar 26, 2025
pulisher
Mar 25, 2025

Akoya Biosciences Shares Fall After Downgrade From Stephens - MarketScreener

Mar 25, 2025
pulisher
Mar 25, 2025

Goldman Sachs To Rally Around 8%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga

Mar 25, 2025
pulisher
Mar 25, 2025

This Brown & Brown Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Benzinga

Mar 25, 2025
pulisher
Mar 25, 2025

Stephens Downgrades Akoya Biosciences to Equalweight From Overweight, Price Target is $1.80 - Marketscreener.com

Mar 25, 2025
pulisher
Mar 24, 2025

Tikvah to oppose Quanterix-Akoya Biosciences merger By Investing.com - Investing.com Australia

Mar 24, 2025
pulisher
Mar 24, 2025

Tikvah to oppose Quanterix-Akoya Biosciences merger - Investing.com India

Mar 24, 2025
pulisher
Mar 24, 2025

Tikvah Management Announces Intention to Vote AGAINST Quanterix’s Proposed Merger with Akoya Biosciences - Business Wire

Mar 24, 2025
pulisher
Mar 24, 2025

Tikvah Management Announces Intention to Vote AGAINST Quanterix's Proposed Merger with Akoya Biosciences - Marketscreener.com

Mar 24, 2025
pulisher
Mar 24, 2025

Key Investor Fights Back: Quanterix Merger Under Fire Over Valuation Concerns - Stock Titan

Mar 24, 2025
pulisher
Mar 24, 2025

Akoya Biosciences (AKYA) to Release Quarterly Earnings on Monday - Defense World

Mar 24, 2025
pulisher
Mar 20, 2025

Akoya Biosciences Reports 2024 Financial Results - TipRanks

Mar 20, 2025
pulisher
Mar 20, 2025

Akoya Biosciences (AKYA) Reports Q4 Loss, Lags Revenue Estimates - MSN

Mar 20, 2025
pulisher
Mar 20, 2025

Stephens Reaffirms “Overweight” Rating for Akoya Biosciences (NASDAQ:AKYA) - The AM Reporter

Mar 20, 2025
pulisher
Mar 19, 2025

Akoya Biosciences (NASDAQ:AKYA) Receives Overweight Rating from Stephens - Defense World

Mar 19, 2025
pulisher
Mar 18, 2025

Akoya Biosciences Shares Down 6.4% After Stock Offering… -June 08, 2023 at 10:10 am EDT - Marketscreener.com

Mar 18, 2025
pulisher
Mar 18, 2025

Akoya Biosciences stock hits 52-week low at $1.43 amid market challenges By Investing.com - Investing.com South Africa

Mar 18, 2025
pulisher
Mar 18, 2025

Akoya Biosciences stock hits 52-week low at $1.43 amid market challenges - Investing.com Australia

Mar 18, 2025
pulisher
Mar 18, 2025

Akoya: Q4 Earnings Snapshot - Milford Mirror

Mar 18, 2025
pulisher
Mar 17, 2025

Akoya Biosciences earnings missed by $0.01, revenue topped estimates - Investing.com Australia

Mar 17, 2025
pulisher
Mar 17, 2025

Akoya Biosciences, Inc. Q4 Loss Decreases, But Misses Estimates - Nasdaq

Mar 17, 2025
pulisher
Mar 17, 2025

Akoya Biosciences, Inc. SEC 10-K Report - TradingView

Mar 17, 2025
pulisher
Mar 17, 2025

Kent Lake urges Quanterix to address questions regarding Akoya deal -March 17, 2025 at 04:28 pm EDT - Marketscreener.com

Mar 17, 2025
pulisher
Mar 17, 2025

Akoya Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView

Mar 17, 2025
pulisher
Mar 17, 2025

Akoya Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results Amid Pending Acquisition by Quanterix Corporation - Nasdaq

Mar 17, 2025
pulisher
Mar 17, 2025

Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results - GlobeNewswire

Mar 17, 2025
pulisher
Mar 17, 2025

Quanterix Merger Under Fire: Top Investor Reveals Shocking 82% Value Disparity - Stock Titan

Mar 17, 2025
pulisher
Mar 17, 2025

Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today’s Earnings Call - Bluefield Daily Telegraph

Mar 17, 2025
pulisher
Mar 15, 2025

Akoya Biosciences, Inc. (NASDAQ:AKYA) Given Consensus Rating of “Hold” by Brokerages - Defense World

Mar 15, 2025
pulisher
Mar 11, 2025

Quanterix Shareholder Opposes Proposed Akoya Biosciences Merger -March 11, 2025 at 10:40 am EDT - Marketscreener.com

Mar 11, 2025
pulisher
Mar 11, 2025

Quanterix Merger Under Fire: 7.25% Stakeholder Reveals Shocking Valuation Concerns - StockTitan

Mar 11, 2025

Akoya Biosciences Inc (AKYA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Akoya Biosciences Inc (AKYA) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
McKelligon Brian
President and CEO
Jun 11 '24
Sale
2.08
7,500
15,630
224,733
McKelligon Brian
President and CEO
Jun 06 '24
Option Exercise
0.30
7,500
2,272
232,233
McKelligon Brian
President and CEO
Jun 06 '24
Sale
2.01
7,500
15,064
224,733
$64.64
price up icon 1.20%
$174.34
price up icon 1.24%
$57.73
price up icon 1.30%
medical_instruments_supplies BAX
$29.03
price up icon 0.98%
medical_instruments_supplies WST
$208.38
price up icon 1.47%
medical_instruments_supplies COO
$79.42
price up icon 1.19%
大文字化:     |  ボリューム (24 時間):